Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa.
about
Identifying Recent HIV Infections: From Serological Assays to GenomicsSurveillance of transmitted antiretroviral drug resistance among HIV-1 infected women attending antenatal clinics in Chitungwiza, ZimbabweControlling HIV epidemics among injection drug users: eight years of Cross-Border HIV prevention interventions in Vietnam and ChinaPerformance of risk-based criteria for targeting acute HIV screening in San Francisco"Get back to where you once belonged": monitoring the AIDS pandemic in the 21st century.A general HIV incidence inference scheme based on likelihood of individual level data and a population renewal equation.Measuring the HIV Care Continuum Using Public Health Surveillance Data in the United States.Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmationEstimating incidence from prevalence in generalised HIV epidemics: methods and validation.HIV incidence in rural South Africa: comparison of estimates from longitudinal surveillance and cross-sectional cBED assay testingErrors in 'BED'-derived estimates of HIV incidence will vary by place, time and ageEstimation of HIV-1 incidence among five focal populations in Dehong, Yunnan: a hard hit area along a major drug trafficking routeCan HIV incidence testing be used for evaluating HIV intervention programs? A reanalysis of the Orange Farm male circumcision trial (ANRS-1265)Better control of early viral replication is associated with slower rate of elicited antiviral antibodies in the detuned enzyme immunoassay during primary HIV-1C infection.High-accuracy identification of incident HIV-1 infections using a sequence clustering based diversity measure.Dual testing algorithm of BED-CEIA and AxSYM Avidity Index assays performs best in identifying recent HIV infection in a sample of Rwandan sex workersApplication of the BED capture enzyme immunoassay for HIV incidence estimation among female sex workers in Kaiyuan City, China, 2006-2007.Augmented cross-sectional prevalence testing for estimating HIV incidenceMore and better information to tackle HIV epidemics: towards improved HIV incidence assays.Acute HIV-1 infection is highly prevalent in Ugandan adults with suspected malaria.Estimation of HIV incidence in the United States.Assessment of ambiguous base calls in HIV-1 pol population sequences as a biomarker for identification of recent infections in HIV-1 incidence studies.Using tests for recent infection to estimate incidence: problems and prospects for HIVA likelihood estimation of HIV incidence incorporating information on past prevalence.Recent HIV-1 infection: identification of individuals with high viral load setpoint in a voluntary counselling and testing centre in rural Mozambique.Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infection.Low incidences of human immunodeficiency virus and hepatitis C virus infection and declining risk behaviors in a cohort of injection drug users in Chennai, India.Antibody maturation and viral diversification in HIV-infected women.High percentage of recent HIV infection among HIV-positive individuals newly diagnosed at voluntary counseling and testing sites in Poland.Towards estimation of HIV-1 date of infection: a time-continuous IgG-model shows that seroconversion does not occur at the midpoint between negative and positive tests.Misclassification of recent HIV-1 seroconversion in sub-Saharan Africa using the sensitive/less sensitive technique.Estimating the HIV incidence rate: recent and future developments.Estimated incidence and genotypes of HIV-1 among pregnant women in central Brazil.Estimating HIV Incidence in Populations Using Tests for Recent Infection: Issues, Challenges and the Way Forward.Human leukocyte antigen variants B*44 and B*57 are consistently favorable during two distinct phases of primary HIV-1 infection in sub-Saharan Africans with several viral subtypes.Estimates of HIV incidence among drug users in St. Petersburg, Russia: continued growth of a rapidly expanding epidemic.Association of recent HIV infection and in-utero HIV-1 transmission.CD4:CD8 lymphocyte ratio as a quantitative measure of immunologic health in HIV-1 infection: findings from an African cohort with prospective data.How can we better identify early HIV infections?Trends of HIV-1 incidence with credible intervals in Sweden 2002-09 reconstructed using a dynamic model of within-patient IgG growth
P2860
Q26778001-476BD866-D78F-4491-8CC9-350EDA19A429Q28478615-69A56480-9703-467D-8766-2628167D9072Q28482694-2B5198A9-E331-4E44-90CA-0E818CEBB746Q28742841-AC5AED6D-A722-4930-895C-B3440549A797Q30372432-04248A4C-F3A7-4012-B245-9E659D3E0ED1Q30566307-908FEB46-FE05-4D14-93B0-084424C295EFQ30986216-379E084E-7002-41A4-B3DA-96D155E6388DQ33308261-5A1F329C-1B4A-4195-A978-4F708D054751Q33347813-8E811DBC-A94F-43BE-A5AA-5F61DE5F61BFQ33382365-9508B5D8-AD48-4F6D-8D16-2C94EF109024Q33455728-C1367DA2-38E8-4362-BD1A-838D149A6772Q33550575-67956196-1CA4-4F58-9D7B-E28A23278E63Q33589257-5DB22AD7-6FE0-4572-81E8-9F12F769F72FQ33625545-87B4C62B-D4A6-4D21-8519-40860C166213Q33748868-033DF044-C4BC-42AC-B568-AD9C1EA7F618Q33885838-D5E0428A-577C-4CAD-ABB0-C714B2523982Q33915306-5ACC9654-777D-4044-94AF-7ED6B1ACBDC6Q33928033-243DFC30-C155-4BF0-9ABB-87EB3C1E7FFFQ33951907-263543C5-9E4B-4D4C-90A7-A84D41E82914Q34019213-82E1A561-8361-4F89-8A24-27D2D1BD0154Q34056420-3A415438-C2C3-4FDA-A3D9-19DE7301DB67Q34058732-66183A36-DEB7-450F-B452-97C0CC25CB2DQ34119836-A2801D58-D22C-4F20-98ED-1BA95709D4B1Q34142137-DD167C3B-A0AA-49C5-8D39-187F01733B66Q34171462-E8DC14E1-4803-43D5-A1D0-46D78641A721Q34231138-A422C485-0941-4DBA-B202-CBCE2E182089Q34514182-CA4F340A-9073-4D76-A2F2-BC61A3E9F60BQ34608508-FB31ABAB-D64E-4058-9D03-9B369D7501E0Q34647528-C812DD9F-CDA8-4835-B14B-4C879AF925C7Q34683831-EC2BC8F4-618A-4040-B5D3-194B5224DDD8Q34871645-BA38FB1C-8B6D-456B-AC10-8EDD3044CAEEQ34876939-9772081F-D2D7-418A-947D-70E9A80DD1D4Q35041199-853553A8-7CCB-476A-8840-FB44411AE46CQ35088760-B9C1DE69-FD24-40F1-9A07-357EA025D8B2Q35192955-46CD7256-B5D0-437A-86CB-22DD0AB8DFBDQ35233606-E9E25788-1E0E-40E6-97CB-7A37374ACCDDQ35688075-5758C011-4CA9-49C9-841F-42676BACD773Q35697246-A61CFF9C-9B73-4ADB-A47D-61B34C905EC2Q35814304-188BA69E-5F34-488A-9614-892FCA550EB9Q35905630-430FCDF0-1D01-4D6C-9083-5618D0577ED7
P2860
Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Investigating the utility of t ...... nverter specimens from Africa.
@en
type
label
Investigating the utility of t ...... nverter specimens from Africa.
@en
prefLabel
Investigating the utility of t ...... nverter specimens from Africa.
@en
P2093
P50
P1433
P1476
Investigating the utility of t ...... nverter specimens from Africa.
@en
P2093
Elwyn Chomba
Eric Hunter
IAVI Collaborative Seroprevalence and Incidence Study Team
Michael Katende
Nzeera Ketter
Susan Allen
P304
P356
10.1097/QAD.0B013E32801481B7
P407
P577
2007-02-01T00:00:00Z